Home
About
Overview
Sharing Data
ORCID
Help
History (5)
Development of food-grade nanoemulsions and emulsions for delivery of omega-3 fatty acids: opportunities and obstacles in the food industry.
Docetaxel and exisulind in previously treated non-small cell lung cancer (NSCLC) patients: a multicenter, phase II clinical trial.
Gene Drives: Biological Shield or Ecological Menace?
Science Policy and Funding Implications of the 2020 U.S. Election.
Therapeutic Advances in Germany and Beyond.
See All 5 Pages
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Therapeutic Advances in Germany and Beyond.
Flotte TR. Therapeutic Advances in Germany and Beyond. Hum Gene Ther. 2017 12; 28(12):1117.
View in:
PubMed
subject areas
Cell- and Tissue-Based Therapy
Congresses as Topic
Genetic Therapy
Germany
Humans
Societies, Medical
authors with profiles
Terence R Flotte MD